Top compounds associated with response to MYO1D


Feature Type Standardized
Nominal ANOVA
mRNA embelin GDSC1000 pan-cancer AAC -0.12 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA TGX221 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA Y-39983 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA simvastatin CTRPv2 pan-cancer AAC -0.13 0.002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Panobinostat CCLE pan-cancer AAC 0.14 0.002
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.12 0.002
mRNA lapatinib CCLE pan-cancer AAC 0.15 0.002
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV